Citations
In this study, we evaluate hematologic change of iron and vitamin B12 on post-operative anemia after gastrectomy for gastric cancer.
The patients with gastric cancer who underwent gastrectomy between January 2013 and December 2013 in Dankook university hospital were retrospectively reviewed. The 62 patients were followed up for 36 month postoperatively.
The incidences of anemia in female patients were turned out to be higher than those in male patients but there were no statistical difference; (44.4% vs 40.9%, P=0.399) at 6 month, (33.3% vs 25.0%, P=0.252) at 12 month, (22.2% vs 15.9%, P=0.277) at 18 month, (27.8% vs 15.9%, P=0.142) at 36 month after surgery. Patients with distal gastrectomy after the surgery showed decreasing incidence of anemia while patients with total gastrectomy showed decreasing incidence of anemia until 12 months but increasing incidence after that time.
Anemia, Vitamin B12 and iron deficiency must be evaluated after surgery for gastric cancer and active treatment is necessary as needed.
Citations
Biliary atresia (BA) is a major cause of extrahepatic biliary obstruction in children. Malnutrition is a significant clinical problem in children with BA. BA may induce the malabsorption of fat and fat-soluble vitamins, resulting in cholestasis and an impaired nutritional status. For the treatment of BA, it is most important to reconstruct the bile flow as early as possible by performing a Kasai portoenterostomy. After the Kasai operation, growth and nutrition are restored, but to follow normal growth and development, it is necessary to evaluate the nutritional status and support. Therefore, the purpose of nutritional support in children with BA is to normalize growth and development, prevent further liver damage and deterioration of the patient’s nutritional status, avoid vitamin and mineral deficiencies, and improve the quality of life of patients.
Vitamin D deficiency is a commonly observed global phenomenon in both the general population as well as hospitalized patients, especially critically ill patients. Many studies have demonstrated an association between vitamin D deficiency and risk of chronic diseases, including cardiovascular disease, diabetes, cancers, autoimmune diseases, and infectious diseases. Vitamin D deficiency is also associated with multiple adverse health outcomes, including increased morbidity and mortality in critically ill patients. The purpose of this review article is to present the current knowledge of clinical outcomes as well as the positive and adverse effects of vitamin D supplements on the relationship between vitamin D status and critical illness. In addition, future strategies for dealing with vitamin D deficiency are suggested.